<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Peptide Industry Gossip</title>
    <link>https://www.peptideindustrygossip.com/</link>
    <description>The tips, the chatter, the product drops, and the receipts.</description>
    <language>en-us</language>
    <atom:link href="https://www.peptideindustrygossip.com/rss.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>What happened to Apex Peptides? Federal agents searched Apex Waste Management; storefront reported closed</title>
      <link>https://www.peptideindustrygossip.com/stories/what-happened-to-apex-peptides</link>
      <guid isPermaLink="true">https://www.peptideindustrygossip.com/stories/what-happened-to-apex-peptides</guid>
      <pubDate>Mon, 05 Oct 2026 12:00:00 GMT</pubDate>
      <category>RECEIPTS</category>
      <description>What happened to Apex Peptides: Postal Inspection Service-led agents searched Apex Waste Management in North Sioux City, SD on Sept. 23. What is confirmed and every source.</description>
    </item>
    <item>
      <title>FDA tells five peptide sellers “research use only” labels do not exempt their injectables</title>
      <link>https://www.peptideindustrygossip.com/stories/fda-warning-letters-five-peptide-sellers-september-2026</link>
      <guid isPermaLink="true">https://www.peptideindustrygossip.com/stories/fda-warning-letters-five-peptide-sellers-september-2026</guid>
      <pubDate>Mon, 05 Oct 2026 12:00:00 GMT</pubDate>
      <category>FDA FILE</category>
      <description>FDA warning letters posted Sept. 1, 2026 name Tex, Royal, NuScience, Peptide Partners and Peak Performance Peptides. What FDA says and the response deadline.</description>
    </item>
    <item>
      <title>Paradigm Peptides owner sentenced to 5 years 10 months for selling unapproved drugs and mislabeled testosterone</title>
      <link>https://www.peptideindustrygossip.com/stories/paradigm-peptides-owner-sentenced-july-2026</link>
      <guid isPermaLink="true">https://www.peptideindustrygossip.com/stories/paradigm-peptides-owner-sentenced-july-2026</guid>
      <pubDate>Mon, 05 Oct 2026 12:00:00 GMT</pubDate>
      <category>RECEIPTS</category>
      <description>The owner of Paradigm Peptides in Michigan City, Indiana was sentenced July 30, 2026 to 70 months. What the U.S. Attorney’s case page says and what it does not.</description>
    </item>
    <item>
      <title>FDA advisory panel backs six of seven peptides, including BPC-157, for the compounding list</title>
      <link>https://www.peptideindustrygossip.com/stories/fda-advisory-panel-backs-six-peptides-compounding-july-2026</link>
      <guid isPermaLink="true">https://www.peptideindustrygossip.com/stories/fda-advisory-panel-backs-six-peptides-compounding-july-2026</guid>
      <pubDate>Mon, 05 Oct 2026 12:00:00 GMT</pubDate>
      <category>FDA FILE</category>
      <description>FDA’s Pharmacy Compounding Advisory Committee met July 23-24, 2026 on seven peptides including BPC-157. What was decided, what is not final, and the sources.</description>
    </item>
    <item>
      <title>FDA sends warning letters to five peptide sellers that also offered bacteriostatic water</title>
      <link>https://www.peptideindustrygossip.com/stories/fda-warning-letters-five-peptide-sellers-march-2026</link>
      <guid isPermaLink="true">https://www.peptideindustrygossip.com/stories/fda-warning-letters-five-peptide-sellers-march-2026</guid>
      <pubDate>Mon, 05 Oct 2026 12:00:00 GMT</pubDate>
      <category>FDA FILE</category>
      <description>FDA warning letters posted Apr. 7, 2026 went to Pink Pony Peptides, Gram Peptides, Prime Sciences, Mile High Compounds and PekCura Labs. What FDA cited.</description>
    </item>
    <item>
      <title>FDA sends warning letters to four research-peptide sellers over semaglutide and retatrutide products</title>
      <link>https://www.peptideindustrygossip.com/stories/fda-warning-letters-four-research-peptide-sellers-december-2024</link>
      <guid isPermaLink="true">https://www.peptideindustrygossip.com/stories/fda-warning-letters-four-research-peptide-sellers-december-2024</guid>
      <pubDate>Mon, 05 Oct 2026 12:00:00 GMT</pubDate>
      <category>FDA FILE</category>
      <description>FDA warning letters posted Dec. 17, 2024 went to Prime Peptides, Swisschems, Xcel Research and Summit Research Peptides. What FDA cited and the response deadline.</description>
    </item>
  </channel>
</rss>
